Nektar Therapeutics Strengthens Board of Directors with Appointment of Diana M. Brainard, M.D.

SAN FRANCISCO: SAN FRANCISCO, Nov. 15, 2021 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced it has appointed Diana M. Brainard, M.D., as an independent director to its Board of Directors. Dr. Brainard brings over two decades of experience working in the healthcare sector and academia to Nektar. She currently...

Click to view original post